SciELO - Scientific Electronic Library Online

 
vol.34 issue2Plasticity of the nervous system: a reviewPermanent depression and temporal lobe epilepsy author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

Share


Arquivos de Neuro-Psiquiatria

Print version ISSN 0004-282X

Arq. Neuro-Psiquiatr. vol.34 no.2 São Paulo June 1976

http://dx.doi.org/10.1590/S0004-282X1976000200007 

A acetamida de pirrolidona como medicação auxiliar no tratamento da paralisia cerebral

 

Pyrrolidone acetamide as an auxiliary drug in the treatment of cerebral palsy

 

 

Francisca Salete Pinheiro Chagas RibeiroI; Penildon SilvaII; Maria Lúcia Villas Boas DoriaIII; Alza de Oliveira LimaIV; Marisa Prates CamposV; Antonieta Novaes FerreiraVI; Maria Júlia Passos Rocha SantosVI; Regina Lúcia ÁvilaVI; Ione da Silva MartinsVI

IPediatra, Diretora Técnica do Instituto Bahiano de Reabilitação
IITitular de Farmacologia do Instituto de Ciências da Saúde da Universidade Federal da Bahia
IIIPsicopedagoga. Instituto de Ciências da Saúde da Universidade Federal da Bahia
IVFisioterapeuta especialista em Bobath. Instituto de Ciências da Saúde da Universidade Federal da Bahia
VFisioterapeuta. Instituto de Ciências da Saúde da Universidade Federal da Bahia
VIProfessora especializada em excepcionais. Instituto de Ciências da Saúde da Universidade Federal da Bahia

 

 


RESUMO

Vinte crianças, com diagnóstico de paralisia cerebral (PC) e sob tratamento clássico, fisioterápico e pedagógico, receberam piracetam (acetamida de pirrolidona) como medicação auxiliar. O objetivo foi melhorar os problemas de espasticidade, apredizagem, neurolabilidade, visando a um rendimento melhor do tratamento global da PC. O grupo medicado foi comparado com um grupo controle de 20 crianças que só eram objeto do tratamento habitual. A comparação mostrou resultados favoráveis no grupo medicado. A droga foi administrada na dose de 80 mg/kg/dia durante 10 semanas. Os critérios de avaliação dos resultados foram psicológicos, clínico, fisioterápico e pedagógico. A droga foi administrada em nova forma de apresentação: solução, para uso oral, a 6%.


SUMMARY

Twenty children, with the diagnosis of cerebral palsy (CP) and under classical, physiotherapeutical and pedagogical, treatment, received piracetam (pyrrolidine acetamide) as an auxiliary drug. The goal was to better spasticity, learning and nervous instability problems aiming at better results of over-all treatment of CP. The group that received the drug has been compared to a control group of 20 children treated by the customary treatment only. The comparison showed favourable results for the medicated group. The drug was administered in the dose of 80 mg/kg/day during 10 weeks. The criteria for evaluation have been psychological, clinical, physiotherapeutical and pedagogical. The drug has been given in a new form of presentation: 6% solution for oral use.


 

 

Texto completo disponível apenas em PDF.

Full text available only in PDF format.

 

 

REFERENCIAS

1. AMPHOUX, G.; NONNAURE, C.; NORLOCK, B. & SAGNES, J. — Etude preliminaire de l'action de l'UCB 6215 sur troubles de la conscience des traumatismes craniens et des accidents vasculaires cérébraux. An. Congrès de Psychiatrie et de Neurologie de Langue Française, Caen, 5-10 juillet, 1971.         [ Links ]

2. BARTRAM, J. B. — Cerebral Palsy. In EMERSON, WALDO E.; VAUGHAM, V. C. & McKAY, R. J. — Textbook of Pediatrics. W. B. Saunders Co. Philadelphia, 1969.         [ Links ]

3. BERTRAND, C. — Intérêt du piracetam comme correcteur de la dysmnesie consecutive à la sismothérapie. An Congrè de Psychiatiíe et de Neurologie de Langue Française, Caen, 5-10 juillet, 1971.         [ Links ]

4. BOBATH, K. & BOBATH, B. — The diagnosis of cerebral palsy in infancy. Arch. Dis. Childhood 31:408, 1956.         [ Links ]

5. DURAD, H. & SOLOMONOVICI, A. M. — Intérêt de l'utilisation du piracetam (UCB 6215) dans les troubles de l'adaptation de l'enfant. Med. Infant. 78:478, 1971.         [ Links ]

6. FERREY, G. & BOUTIER, D. — Les syndromes subjectifs des traumatisés du crâne vus dans un service d'hôspital général en un an: utilisation de l'UCB 6215. Thérapeutique 48:143, 1972.         [ Links ]

7. GIURGEA, C.; MOYERSOONS, F. & EVRAERD, A. C. — A gaba-related hypotesis on the mechanism of action of the antimotion sickness drugs. Arch. Int. Pharmacodyn. Ther. 166:238, 1967.         [ Links ]

8. GIURGEA, C.; MOURAVIEFF-LESUISSE, F. & LEEMANS, R. — Corrélations électro-pharmacologiques au cours de l'anoxie oxyprive chez le lapin en respiration libre ou artificielle. Rev. Neurol. (Paris) 122:484, 1970.         [ Links ]

9. GIURGEA, C. E. & MOYERSOONS, F. — Differential pharmacological reactivity of three types of cortical evoked potentials. Arch. Int. Pharmacodyn. Therap. 188:401, 1970.         [ Links ]

10. GIURGEA, C.; LEFÊVRE, D.; LESCRENIER, C. & DAVID-REMACLE, M. — Pharmacological protection against hipoxia-induced amnesis in rats. Psychopharmacol. 20:160, 1971.         [ Links ]

11. GIURGEA, C. & MOURAVIEFF-LESUISSE, F. — Pharmacological studies on an elementary model of learning — the fixation of an experience at spinal level: part I: Pharmacological reactivity of the spinal cord fixation time. Arch. Int. Pharmacodyn. Ther. 191:279, 1971.         [ Links ]

12. GIURGEA, C. & MOURAVIEFF-LESUISSE, F. — Effect facilitateur du piracetam sur un apprentissage répetitif chez le rat. J. Pharmacol. 3:17, 1972.         [ Links ]

13. GIURGEA, C. E. — Vers une pharmacologie de l'activité intégrative du cerveau: tentative du concept nootrope en psychopharmacologie. Acta Pharmacol. 25:115, 1972.         [ Links ]

14. GOBERT, J. G. — Genèse d'un médicament: le piracetam; metabolisation et recherche biochimique. J. Pharmacie Belgique 27:281, 1972.         [ Links ]

15. HOTERMANS, J. M.; VAN DAELE, G. & SCHELLE KENS, K. — Étude pilote du pirrolidone acétamide ou piracetam en Neurologie et Neurochirurgie, portant sur 220 observations. An. Reunion Commune de Neurochirurgie, Bruxelles, juin, 1971.         [ Links ]

16. LOW, R.; MELLO, P. A. & HENRIQUES, F. G. — Ação do piracetam em crianças com paralisia cerebral Rev. Bras. Clin. Terap. 4:409, 1975.         [ Links ]

17. MOURAVIEFF-LESUISSE, F. & GIURGEA, C. E. — Pharmacological reactivity of an experimental model of memory: the spinal cord fixation. Arch. Int. Pharmacodyn. Ther. 176:471, 1968.         [ Links ]

18. PEDE, J. P.; SCHIMPFESSEL, L. & CROKAERT, R. — The action of piracetam on the oxidative phosphorylation. Arch. Int. Physiol. Bioch. 79:1036, 1971.         [ Links ]

19. SARA, S. J. & LEFÈVRE, D. — Hypoxia-induced amnesia in one-trial learning and pharmacological protection by piracetam. Psycho-pharmacol. 25:32, 1972.         [ Links ]

20. STRUBBE, J. H. & CYPRYSIAK, E. — Dérivés de l'acide (2-oxo-pyrrolidine) acétique. Rev. Ind. Chim. Beige 32:112, 1967.         [ Links ]

21. THIEBAULD, M. — Amélioration des performances intelectuelles. Contribution d'une thérapeutique corticale specifique. An. Congrès Français de Medecine, Beyrouth, 12-16 sept, 1971.         [ Links ]

22. TOSCANO, M.; MENDLEWICZ, J. & BOON, H. — Bilan de deux ans d'utilisation du piracetam (UCB 6215) en clinique psychiatrique. An. Congrès de Psychiatrie et de Neurologie de Langue Française, Caen, 5-10 juillet, 1971.         [ Links ]

23. TURON, R.; FLORENCE, J. & PRAT, R. — Perspectives thérapeutiques de l'UCB 6215 — plracetam — dans les états de détresse cérébrale algüe, les séquelles de traumatismes et leurs altérations électroeneephalographiques. An. Congrès de Psyihiatrie et de Neurologie de Langue Francaise, Caen, 5-10 juillet, 1971.         [ Links ] 24. TURON, R. & FLORENCE, J. — Résultats de 1'expérimentation thérapeutique du plracetam (2-pyrrolidone acétamide) UCB 6215 dans les accidents vasculalres cérébraux (100 cas). An. Journées Int. de Circulation Cérébrale, Toulouse, 21-22 avril, 1972.         [ Links ]

25. WECKROTH, J. & MIKKONEN, H. — Effet de 1'UCB 6215 sur certains traits de performance intelectuelle, perceptuelle et psychomotrice et sur des traits d'états mentaux jugés subjectivement. An 30th Congres on Alcoholism and Drug Dependence, Amsterdan, 4-9 sept, 1972.         [ Links ]

26. WOLTHUIS, O. L. — Experiments with UCB 6215 a drug which enhances acquisitions in rats: its effects compared with those of metamphetamine. Eur. J. Pharmacol. 16:283, 1971.         [ Links ]

 

 

Instituto Bahiano de Reabilitação — Av. Presidente Vargas — 4OOOO Salvador, BA — Brasil.
Trabalho realizado no Instituto Bahiano de Reabilitação, apresentado no VT Congresso Brasileiro de Paralisia Cerebral (Salvador, BA, 12 a 17 de outubro de 1975)

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License